Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake
暂无分享,去创建一个
Kenneth G. C. Smith | N. McGovern | M. Clatworthy | D. Adu | V. Plagnol | Y. Lau | A. Morgan | P. Lyons | E. Chilvers | Wanling Yang | James I. Robinson | L. Willcocks | A. Condliffe | R. Watts | R. Watts | Dwomoa Adu | Naomi N. McGovern | G. Nash | E. C. Jolly | Stephen A. Newland | J. Robinson | Ann W. Morgan | Vincent Plagnol | JI Robinson | Vincent Plagnol | Yu-Lung Lau | Paul A. Lyons | Gerard B. Nash | Kenneth G. C. Smith | Stephen A. Newland | Vincent Plagnol | Naomi N. McGovern | E. Chilvers | Elaine C. Jolly | Richard Watts | Yu Lung Lau | Ann W. Morgan | Y. Lau | Ann W Morgan
[1] S. Mccarroll. Copy-number analysis goes more than skin deep , 2008, Nature Genetics.
[2] S. Mccarroll,et al. Copy-number variation and association studies of human disease , 2007, Nature Genetics.
[3] Bi Zhou,et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. , 2007, American journal of human genetics.
[4] Philippe Froguel,et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity , 2007, Nature Genetics.
[5] Lorraine Potocki,et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. , 2007, American journal of human genetics.
[6] R. Redon,et al. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.
[7] Kenneth G. C. Smith,et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification , 2007, BMC Genomics.
[8] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[9] Steve Burke,et al. CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. , 2006, Blood.
[10] Kenneth G. C. Smith,et al. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. , 2006, Arthritis and rheumatism.
[11] R. Redon,et al. Copy Number Variation: New Insights in Genome Diversity References , 2006 .
[12] Xiaomei Lu,et al. Capture of flowing human neutrophils by immobilised immunoglobulin: roles of Fc-receptors CD16 and CD32. , 2006, Cellular immunology.
[13] Enrico Petretto,et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans , 2006, Nature.
[14] J. Ravetch,et al. Fcgamma receptors: old friends and new family members. , 2006, Immunity.
[15] J. Ravetch,et al. Fcgamma receptors: old friends and new family members. , 2006, Immunity.
[16] G. Paré,et al. CD16b associates with high-density, detergent-resistant membranes in human neutrophils. , 2006, The Biochemical journal.
[17] B. Rovin,et al. The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .
[18] G. Hänsch,et al. Genetic deficiency of CD16, the low‐affinity receptor for immunoglobulin G, has no impact on the functional capacity of polymorphonuclear neutrophils , 2004, European journal of clinical investigation.
[19] G. Cooper,et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. , 2003, Arthritis and rheumatism.
[20] K. Tokunaga,et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. , 2003, Tissue antigens.
[21] C. Kallenberg,et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. , 2002, Arthritis and rheumatism.
[22] E. Brown,et al. Cr3 (mac-l, Cgm 2, Cdllb/cd18) and Fc /riii Cooperate in Generation of a Neutrophil Respiratory Burst: Requirement for Fctrii and Tyrosine Phosphorylation , 1994 .
[23] T. Mayadas,et al. Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. , 2001, Immunity.
[24] D. Adu,et al. Neutrophil FcγRIIIb allelic polymorphism in anti‐neutrophil cytoplasmic antibody (ANCA)‐positive systemic vasculitis , 2000, Clinical and experimental immunology.
[25] P. McKeigue,et al. Risk for rheumatic disease in relation to ethnicity and admixture , 2000, Arthritis research.
[26] C. Savage,et al. Pathogenesis of ANCA‐associated systemic vasculitis , 2000, The Journal of pathology.
[27] J. Unkeless,et al. Convergence of Fcγ Receptor IIA and Fcγ Receptor IIIB Signaling Pathways in Human Neutrophils1 , 2000, The Journal of Immunology.
[28] J. Unkeless,et al. Convergence of Fc gamma receptor IIA and Fc gamma receptor IIIB signaling pathways in human neutrophils. , 2000, Journal of immunology.
[29] K. Huppi,et al. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. , 1999, Blood.
[30] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[31] G. Achtert,et al. Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for FcγRI, II and III , 1997, Annals of Hematology.
[32] J. Galon,et al. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. , 1996, Journal of immunology.
[33] P. Anderson,et al. Ligand binding and phagocytosis by CD16 (Fc gamma receptor III) isoforms. Phagocytic signaling by associated zeta and gamma subunits in Chinese hamster ovary cells. , 1995, The Journal of biological chemistry.
[34] D. Roos,et al. Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. , 1995, Blood.
[35] R. Kimberly,et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. , 1994, Journal of immunology.
[36] A. Borne,et al. The plasma concentration of soluble Fc‐gamma RIII is related to production of neutrophils , 1994, British journal of haematology.
[37] E. Brown,et al. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation , 1994, The Journal of cell biology.
[38] M. Walport,et al. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. , 1992, The Journal of clinical investigation.
[39] R. Kimberly,et al. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. , 1992, The Journal of clinical investigation.
[40] I. Goldstein,et al. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. , 1990, The Journal of clinical investigation.
[41] C. Anderson,et al. Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes , 1990, The Journal of experimental medicine.
[42] K. Dolman,et al. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. , 1990, Journal of immunology.
[43] B. Perussia,et al. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions , 1989, The Journal of experimental medicine.
[44] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[45] H. Cohen,et al. Superoxide production by digitonin-stimulated guinea pig granulocytes. The effects of N-ethyl maleimide, divalent cations; and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system. , 1978, The Journal of clinical investigation.